J Med Microbiol International Journal of Systematic and Evolutionary Microbiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

IMMEDIATE OPEN ACCESS ARTICLE
This Article
Free via Open Access: OA
Right arrow OA Free Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oyston, P. C. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oyston, P. C. F.
Agricola
Right arrow Articles by Oyston, P. C. F.
J Med Microbiol 57 (2008), 921-930; DOI: 10.1099/jmm.0.2008/000653-0
© 2008 Society for General Microbiology
ISSN 1473-5644

Review

Francisella tularensis: unravelling the secrets of an intracellular pathogen

Petra C. F. Oyston

Biomedical Sciences, DSTL Porton Down, Salisbury, Wiltshire SP4 0JQ, UK

Correspondence
Petra C. F. Oyston
pcoyston{at}dstl.gov.uk


Francisella tularensis has been recognized as the causative agent of tularaemia for almost a century. Since its discovery in 1911, it has been shown to infect a wide range of hosts, including humans. As early as the 1920s it was suggested to be an intracellular pathogen, but it has proven to be an enigmatic organism, whose interaction with the host has been difficult to elucidate, and we still have a very limited understanding of the molecular mechanisms of virulence. However, the recent availability of genome sequence data and molecular tools has allowed us to start to understand the molecular basis of F. tularensis pathogenicity, and will facilitate the development of a vaccine to protect against infection.




This article has been cited by other articles:


Home page
 Appl. Environ. Microbiol.Home page
S. H. El-Etr, J. J. Margolis, D. Monack, R. A. Robison, M. Cohen, E. Moore, and A. Rasley
Francisella tularensis Type A Strains Cause the Rapid Encystment of Acanthamoeba castellanii and Survive in Amoebal Cysts for Three Weeks Postinfection
Appl. Envir. Microbiol., December 1, 2009; 75(23): 7488 - 7500.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
H.-C. Chiu, J. Yang, S. Soni, S. K. Kulp, J. S. Gunn, L. S. Schlesinger, and C.-S. Chen
Pharmacological Exploitation of an Off-Target Antibacterial Effect of the Cyclooxygenase-2 Inhibitor Celecoxib against Francisella tularensis
Antimicrob. Agents Chemother., July 1, 2009; 53(7): 2998 - 3002.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
G. S. Schulert, R. L. McCaffrey, B. W. Buchan, S. R. Lindemann, C. Hollenback, B. D. Jones, and L.-A. H. Allen
Francisella tularensis Genes Required for Inhibition of the Neutrophil Respiratory Burst and Intramacrophage Growth Identified by Random Transposon Mutagenesis of Strain LVS
Infect. Immun., April 1, 2009; 77(4): 1324 - 1336.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 2008 Society for General Microbiology.